AI assistant
Egetis Therapeutics Major Shareholding Notification 2022
3152_iss_2022-05-17_1fe58e44-8021-4326-8bf7-f4b3733eeabc.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Egetis Therapeutics AB (publ)
Holder
RegulaPharm AB
Instrument
| Instrument | aktier |
|---|---|
| Before the transaction | |
| Shares | 9,846,730 |
| Voting rights | 9,846,730 |
| Transaction | |
| Reason for major shareholding notification New share issue | |
| Date | 17/05/2022 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 10,531,660 |
| Directly held voting rights | 10,531,660 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.9 % |
| Directly held voting rights | 4.9 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||||
|---|---|---|---|---|---|
| Shares | 4.9 % | 10,531,660 | |||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||||
| - Cash settled | - Physically settled | ||||
| Total | 4.9 % | 10,531,660 | |||
| Published | 17/05/2022 21:53 | ||||
| Contact | |||||
| Name | Gudrun Hörnqvist | ||||
| Phone | 0709321440 Email [email protected] |
||||
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25